Holen Sie sich die Stockscreener-App
1.21
12.95%
-0.18
Vorhandelsmarkt:
1.16
-0.05
-4.13%
Schlusskurs vom Vortag:
$1.39
Offen:
$1.35
24-Stunden-Volumen:
7.01M
Relative Volume:
5.38
Marktkapitalisierung:
$3.96M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.26M
KGV:
-0.0226
EPS:
-53.609
Netto-Cashflow:
$-12.17M
1W Leistung:
-38.89%
1M Leistung:
-30.46%
6M Leistung:
-11.03%
1J Leistung:
-92.32%
1-Tages-Spanne:
$1.1502
$1.35
1-Wochen-Bereich:
$1.1502
$2.17
52-Wochen-Spanne:
$1.10
$16.91
Gri Bio Inc Stock (GRI) Company Profile
Firmenname
Gri Bio Inc
Sektor
Branche
Telefon
(619) 400-1171
Adresse
2223 AVENIDA DE LA PLAYA, LA JOLLA
Vergleichen Sie GRI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GRI
Gri Bio Inc
|
1.21 | 4.54M | 0 | -8.26M | -12.17M | -53.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gri Bio Inc Stock (GRI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-09 | Eingeleitet | H.C. Wainwright | Buy |
Gri Bio Inc Aktie (GRI) Neueste Nachrichten
GRI Bio’s IPF drug shows positive Phase 2a results with improved lung function - Investing.com
GRI Bio Announces Positive Phase 2a Trial Results - TipRanks
GRI Bio, Inc. Announces Positive Phase 2a Trial Results for GRI-0621 - TradingView
GRI Bio (NASDAQ: GRI) unveils Phase 2a IPF results showing favorable safety and collagen biomarker shifts - Stock Titan
A new trading data show Milestone Pharmaceuticals Inc (MIST) is showing positive returns. - Setenews
Financial Contrast: CalciMedica (NASDAQ:CALC) and GRI Bio (NASDAQ:GRI) - Defense World
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.45% - Investing.com UK
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.45% - Investing.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
GRI Bio Reports Positive Phase 2a Trial Results - TipRanks
GRI Bio Increceives topline data from phase 2a trial for idiopathic pulmonary fibrosisSEC filing - marketscreener.com
GRI Bio Reports Positive Phase 2a Trial Results for IPF Treatment - TradingView
Ascendiant Capital Maintains GRI Bio (GRI) Buy Recommendation - Nasdaq
Ascendiant Capital Raises Price Target for GRI to $36.00 | GRI S - GuruFocus
Why GRI Bio Inc. stock is seen as undervaluedSell Signal & Weekly Return Optimization Alerts - Newser
JTC Team Companies to Present in Webull Corporate Connect Webinar Series: Biotech/MedTech on August 19-21, 2025 - The Herald-Mail
GRI Bio receives Nasdaq notice for non-compliance with equity listing rule - Investing.com Australia
GRI Bio (GRI) Stock Analysis Report | Financials & Insights - Benzinga
GRI Bio Inc. (GRI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What insider trading reveals about GRI Bio Inc. stockWeekly Gains Summary & Long-Term Safe Investment Ideas - BỘ NỘI VỤ
Stop Loss: What sentiment indicators say about GRI Bio Inc. stock2025 Retail Activity & Long-Term Growth Portfolio Plans - moha.gov.vn
Buy Signal: What insider trading reveals about GRI Bio Inc. stock2025 Technical Overview & Low Risk Profit Maximizing Plans - moha.gov.vn
This trade activity should not be overlooked: GRI Bio Inc (GRI) - Setenews
Wall Street analysts’ outlook for Moolec Science SA (MLEC) - Setenews
A better buy-in window may exist right now for Movano Inc (MOVE) - Setenews
GRI Bio Inc Stock Analysis and ForecastRisk Mitigation Techniques & Rapid Capital Appreciation - earlytimes.in
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ('IPF') - ADVFN
GRI Stock Price and Chart — NASDAQ:GRI - TradingView
The growth track for GRI Bio Inc (GRI) has changed recently - Setenews
What technical charts say about GRI Bio Inc. stock2025 Price Action Summary & Weekly Setup with High ROI Potential - newser.com
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
How GRI Bio Inc. stock benefits from strong dollarShare Buyback & Free Daily Entry Point Trade Alerts - newser.com
GRI Bio Inc. stock daily chart insightsWeekly Investment Report & Low Drawdown Momentum Ideas - newser.com
Visual analytics tools that track GRI Bio Inc. performanceBond Market & Reliable Price Breakout Signals - newser.com
How supply chain issues affect GRI Bio Inc. stock2025 Top Decliners & Daily Profit Focused Screening - newser.com
Will GRI Bio Inc. stock see insider buyingMarket Growth Summary & Free High Accuracy Swing Entry Alerts - newser.com
Using economic indicators to assess GRI Bio Inc. potentialInsider Selling & Technical Pattern Based Buy Signals - newser.com
Will GRI Bio Inc. stock outperform value stocksJuly 2025 Review & Real-Time Market Sentiment Alerts - newser.com
Technical analysis overview for GRI Bio Inc. stockJuly 2025 Opening Moves & Safe Entry Zone Tips - newser.com
What does recent volatility data suggest for GRI Bio Inc.Quarterly Trade Summary & Verified Short-Term Plans - newser.com
GRI SEC FilingsGRI Bio 10-K, 10-Q, 8-K Forms - Stock Titan
GRI Q3 2025 Earnings Report on 11/14/2025 - MarketBeat
GRI Bio, Inc. SEC 10-Q Report - TradingView
Form 424B3 GRI Bio, Inc. - StreetInsider
GRI: Net loss rose to $9.3M YTD; cash runway extends into Q1 2026, but funding uncertainty remains - TradingView
Finanzdaten der Gri Bio Inc-Aktie (GRI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):